$49.00
Manufacturer: Ukraine
Alzmerat (choline alfoscerate) solution for injections is used for acute period of severe traumatic brain injury with a predominantly stem level of damage (impaired consciousness, coma, focal hemispheric symptoms, symptoms of brain stem damage).
Degenerative-involutional cerebral psychoorganic syndromes or secondary consequences of cerebrovascular insufficiency, that is, primary and secondary mental disorders in the elderly, which are characterized by memory impairment, confusion, disorientation, decreased motivation and initiative, reduced ability to concentrate; changes in the emotional sphere and the sphere of behavior: emotional instability, irritability, indifference to the environment; pseudomelancholia in the elderly.
Description
Composition
active ingredient: choline alfoscerate;
1 ml choline alfoscerate 250 mg
excipients: water for injection.
Indications.
Acute period of severe traumatic brain injury with a predominantly stem level of damage (impaired consciousness, coma, focal hemispheric symptoms, symptoms of brain stem damage).
Degenerative-involutional cerebral psychoorganic syndromes or secondary consequences of cerebrovascular insufficiency, that is, primary and secondary mental disorders in the elderly, which are characterized by memory impairment, confusion, disorientation, decreased motivation and initiative, reduced ability to concentrate; changes in the emotional sphere and the sphere of behavior: emotional instability, irritability, indifference to the environment; pseudomelancholia in the elderly.
Contraindications.
Hypersensitivity to the drug or its components.
During pregnancy and breastfeeding.
Psychotic syndrome with severe psychomotor agitation.
Method of application and dose.
In acute conditions, Alzmerat must be administered intramuscularly or intravenously (slowly) at a dose of 1 g (1 ampoule) for 15-20 days. Then, after stabilization of the patient’s condition, you should switch to the dosage form of the drug in capsules.
Recent Reviews